I am a genitourinary medical oncologist with a particular focus on recurrent and advanced prostate cancer. I conduct clinical and translational studies to bring new therapies to patients with prostate cancer. In particular, I am interested in developing novel androgen-directed therapies, genetically-targeted therapies, and immunotherapies for men with recurrent or advanced prostate cancer, and using germline and tumor genomics to inform precision oncology approaches for these patients. I also have an interest in liquid biomarker development, including the clinical validation of the AR-V7 marker as well as DNA repair markers and their therapeutic implications. I am also involved in mentoring fellows and junior faculty in the clinical care of genitourinary cancers and the development of translational research strategies related to prostate cancer.